Current Report Filing (8-k)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): February 03, 2020

 

SLEEPAID HOLDING CO.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada		000-55446		47-3785730
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

Rm 10 1/F Wellborne Commercial Centre 8 Java Road North Point, Hong Kong

(Address of Principal Executive Office) (Zip Code)

 

Registrant’s telephone number, including area code: (852) 2806-2312

 

____________________________________________

(former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

ITEM 5.02. DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS

 

On December 31^th, 2019, Ms. Qiuli Chen, the Chief Executive Director, and Chief Financial Director of Sleepaid Holding Company (the “Company”) has submitted her resignation for her personal accord to the board. On 3^rd of February, the board accepted Ms. Chen’s resignation, simultaneously, the board appointed Mr. Lowell Holden as the Chief Executive Director, Chief Financial Director of the Company.

 

On May 9^th, 2019, Lowell Holden was appointed as a director of Sleepaid. Mr. Holden has owned and operated his own consulting firm, LS Enterprises, Inc., which provides business consulting, accounting and other services to businesses, since 1983. Mr. Holden has a broad range of business experience including managing, securing financing, structuring of transactions, and is experienced and knowledgeable in managing relationships with customers, financing institutions and stockholders. Presently Mr. Holden serves as the director and Chief Financial officer of Nascent Biotech Inc. (“NBIO”), Chief Financial Officer of Skkynet Cloud Systems, Inc. (“SKKY”), Chief Financial Officer and director of EMR Technology, and Chief Executive Officer and director of PTS, Inc. (“PTSH”). Mr. Holden also has a background in assisting companies in fulfilling their financial auditing and SEC reporting requirements. Mr. Lowell Holden has a Bachelor of Science degree from Iowa State University.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	SLEEPAID HOLDING CO.
Date: February 3rd, 2020	By:	/s/ Lowell Holden
		Lowell Holden, CEO

 

3